STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma

Investor logo

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

PRUTSCH Nicole HE Shuning BEREZOVSKAYA Alla DURBIN Adam D DHARIA Neekesh V MAHER Kelsey A MATTHEWS Jamie D HARE Lucy TURNER Suzanne Dawn STEGMAIER Kimberly KENNER Lukas MERKEL Olaf LOOK A Thomas ABRAHAM Brian J ZIMMERMAN Mark W

Year of publication 2024
Type Article in Periodical
Magazine / Source CELL REPORTS MEDICINE
MU Faculty or unit

Faculty of Medicine

Citation
Web https://www.sciencedirect.com/science/article/pii/S2666379124001186?via%3Dihub
Doi http://dx.doi.org/10.1016/j.xcrm.2024.101472
Keywords anaplastic large cell lymphoma; STAT3
Attached files
Description Anaplastic large cell lymphoma (ALCL) is an aggressive, CD30 + T cell lymphoma of children and adults. ALK fusion transcripts or mutations in the JAK-STAT pathway are observed in most ALCL tumors, but the mechanisms underlying tumorigenesis are not fully understood. Here, we show that dysregulated STAT3 in ALCL cooccupies enhancers with master transcription factors BATF3, IRF4, and IKZF1 to form a core regulatory circuit that establishes and maintains the malignant cell state in ALCL. Critical downstream targets of this network in ALCL cells include the protooncogene MYC , which requires active STAT3 to facilitate high levels of MYC transcription. The core autoregulatory transcriptional circuitry activity is reinforced by MYC binding to the enhancer regions associated with STAT3 and each of the core regulatory transcription factors. Thus, activation of STAT3 provides the crucial link between aberrant tyrosine kinase signaling and the core transcriptional machinery that drives tumorigenesis and creates therapeutic vulnerabilities in ALCL.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info